These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18081089)
1. Transcription-inhibition and antitumor activities of N-alkylated tetraazacyclododecanes. Xiong XQ; Liang F; Yang L; Wang XL; Zhou X; Zheng CY; Cao XP Chem Biodivers; 2007 Dec; 4(12):2791-7. PubMed ID: 18081089 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties. Brachwitz K; Voigt B; Meijer L; Lozach O; Schächtele C; Molnár J; Hilgeroth A J Med Chem; 2003 Feb; 46(5):876-9. PubMed ID: 12593668 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues. Defant A; Guella G; Mancini I Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives. Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones. Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs. Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722 [TBL] [Abstract][Full Text] [Related]
7. 2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study. Drakulić BJ; Juranić ZD; Stanojković TP; Juranić IO J Med Chem; 2005 Aug; 48(17):5600-3. PubMed ID: 16107160 [TBL] [Abstract][Full Text] [Related]
8. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline. Shi C; Wang J; Chen H; Shi D J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973 [TBL] [Abstract][Full Text] [Related]
9. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores. Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 1,5-diazaanthraquinones as antitumour compounds. Avendaño C; Pérez JM; Blanco Mdel M; de la Fuente JA; Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Menéndez JC Bioorg Med Chem Lett; 2004 Aug; 14(15):3929-32. PubMed ID: 15225700 [TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis of 4'-azaflavones and their N-alkyl derivatives with biological activities. Yaşar A; Akpinar K; Burnaz NA; Küçük M; Karaoğlu SA; Doğan N; Yayli N Chem Biodivers; 2008 May; 5(5):830-8. PubMed ID: 18493968 [TBL] [Abstract][Full Text] [Related]
12. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics. Gust R; Ott I; Posselt D; Sommer K J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors. Huang S; Li R; Connolly PJ; Emanuel S; Middleton SA Bioorg Med Chem Lett; 2006 Sep; 16(18):4818-21. PubMed ID: 16870444 [TBL] [Abstract][Full Text] [Related]
14. Relationship between structure and antiproliferative activity of 1-azaflavanones. Kawaii S; Endo K; Tokiwano T; Yoshizawa Y Anticancer Res; 2012 Jul; 32(7):2819-25. PubMed ID: 22753743 [TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research. Menicagli R; Samaritani S; Signore G; Vaglini F; Dalla Via L J Med Chem; 2004 Sep; 47(19):4649-52. PubMed ID: 15341480 [TBL] [Abstract][Full Text] [Related]
16. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities]. Dong XC; Zhou FS; Zheng JB; Wen R Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds. Kossakowski J; Kuran B Acta Pol Pharm; 2008; 65(3):371-5. PubMed ID: 18646557 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents. Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities. Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337 [TBL] [Abstract][Full Text] [Related]